Post-transcriptional regulation of DNA damage-responsive gene expression

Antioxidants and Redox Signaling

Volumn 20, Issue 4, 2014, Pages 640-654

  McKay, Bruce C ^a  

^a CARLETON UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; MESSENGER RNA; PROTEIN P53;

DNA DAMAGE; DNA TEMPLATE; GENE EXPRESSION; GENOMIC INSTABILITY; HUMAN; MESSENGER RNA SYNTHESIS; POST TRANSCRIPTIONAL REGULATION; PRIORITY JOURNAL; REVIEW; RNA METABOLISM; RNA PROCESSING; RNA STABILITY; TRANSCRIPTION REGULATION; ULTRAVIOLET RADIATION;

ANIMALS; DNA DAMAGE; DNA REPAIR; HUMANS; MICRORNAS; RNA INTERFERENCE; RNA STABILITY; TRANSCRIPTION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 84892929915     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5523     Document Type: Review

References (168)

1. Amundson SA, Bittner M, Chen Y, Trent J, Meltzer P, and Fornace AJJ. Fluorescent cDNA microarray hybridization reveals complexity and heterogeneity of cellular genotoxic stress responses. Oncogene 18: 3666-3672, 1999.
2. Bakheet T, Frevel M,Williams BR, Greer W, and Khabar KS. ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins. Nucleic Acids Res 29: 246-254, 2001.
3. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 136: 215-233, 2009.
4. Beckerman R and Prives C. Transcriptional regulation by p53. Cold Spring Harb Perspect Biol 2: 000935, 2010.
5. Beilharz TH, Humphreys DT, Clancy JL, Thermann R, Martin DI, Hentze MW, and Preiss T. microRNA-mediated messenger RNA deadenylation contributes to translational repression in mammalian cells. PLoS One 4: e6783, 2009.
6. Bensimon A, Schmidt A, Ziv Y, Elkon R, Wang SY, Chen DJ, Aebersold R, and Shiloh Y. ATM-dependent and-independent dynamics of the nuclear phosphoproteome after DNA damage. Sci Signal 3: rs3, 2010.
7. Bernstein P, Peltz SW, and Ross J. The poly(A)-poly(A)-binding protein complex is a major determinant of mRNA stability in vitro. Mol Cell Biol 9: 659-670, 1989.
8. Blattner C, Kannouche P, Litfin M, Bender K, Rahmsdorf HJ, Angulo JF, and Herrlich P. UV-Induced stabilization of c-fos and other short-lived mRNAs. Mol Cell Biol 20: 3616-3625, 2000.
9. Bohr VA, Smith CL, Okumoto DS, and Hanawalt PC. DNA repair in an active gene: removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall. Cell 40: 359-369, 1985.
10. Bollig F, Winzen R, Kracht M, Ghebremedhin B, Ritter B, Wilhelm A, Resch K, and Holtmann H. Evidence for general stabilization of mRNAs in response to UV light. Eur J Biochem 269: 5830-5839, 2002.
11. Boominathan L. The tumor suppressors p53, p63, and p73 are regulators of microRNA processing complex. PLoS One 5: e10615, 2010.
12. Bregman A, Avraham-Kelbert M, Barkai O, Duek L, Guterman A, and Choder M. Promoter elements regulate cytoplasmic mRNA decay. Cell 147: 1473-1483, 2011.
13. Bregman DB, Halaban R, van Gool AJ, Henning KA, Friedberg EC, and Warren SL. UV-induced ubiquitination of RNA polymerase II: a novel modification deficient in Cockayne syndrome cells. Proc Natl Acad Sci USA 93: 11586-11590, 1996.
14. Brennan CM and Steitz JA. HuR and mRNA stability. Cell Mol Life Sci 58: 266-277, 2001.
15. Brochu C, Cabrita MA, Melanson BD, Hamill JD, Lau R, Pratt MA, and McKay BC. NF-kappaB-dependent role for cold-inducible RNA binding protein in regulating interleukin 1beta. PLoS One 8: e57426, 2013.
16. Buratowski S. Progression through the RNA polymerase II CTD cycle. Mol Cell 36: 541-546, 2009.
17. Buscher M, Rahmsdorf HJ, Litfin M, Karin M, and Herrlich P. Activation of the c-fos gene by UV and phorbol ester: different signal transduction pathways converge to the same enhancer element. Oncogene 3: 301-311, 1988.
18. Cadet J, Sage E, and Douki T. Ultraviolet radiationmediated damage to cellular DNA. Mutat Res 571: 3-17, 2005.
19. Carballo E, Lai WS, and Blackshear PJ. Feedback inhibition of macrophage tumor necrosis factor-alpha production by tristetraprolin. Science 281: 1001-1005, 1998.
20. Carrier F, Gatignol A, Hollander MC, Jeang KT, and Fornace AJ, Jr. Induction of RNA-binding proteins in mammalian cells by DNA-damaging agents. Proc Natl Acad Sci USA 91: 1554-1558, 1994.
21. Cevher MA and Kleiman FE. Connections between 3¢-end processing and DNA damage response. Wiley Interdiscip Rev RNA 1: 193-199, 2010.
22. Chang TC, Wentzel EA, Kent OA, Ramachandran K, Mullendore M, Lee KH, Feldmann G, Yamakuchi M, Ferlito M, Lowenstein CJ, Arking DE, Beer MA, Maitra A, and Mendell JT. Transactivation of miR-34a by p53 broadly influences gene expression and promotes apoptosis. Mol Cell 26: 745-752, 2007.
23. Chen CY, Gherzi R, Ong SE, Chan EL, Raijmakers R, Pruijn GJ, Stoecklin G, Moroni C, Mann M, and Karin M. AU binding proteins recruit the exosome to degrade AREcontaining mRNAs. Cell 107: 451-464, 2001.
24. Choi YJ, Lin CP, Ho JJ, He X, Okada N, Bu P, Zhong Y, Kim SY, Bennett MJ, Chen C, Ozturk A, Hicks GG, Hannon GJ, and He L. miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol 13: 1353-1360, 2011.
25. Chung S, Jiang L, Cheng S, and Furneaux H. Purification and properties of HuD, a neuronal RNA-binding protein. J Biol Chem 271: 11518-11524, 1996.
26. Corney DC, Flesken-Nikitin A, Godwin AK, Wang W, and Nikitin AY. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth. Cancer Res 67: 8433-8438, 2007.
27. Cramer P, Pesce CG, Baralle FE, and Kornblihtt AR. Functional association between promoter structure and transcript alternative splicing. Proc Natl Acad Sci USA 94: 11456-11460, 1997.
28. Dahan N and Choder M. The eukaryotic transcriptional machinery regulates mRNA translation and decay in the cytoplasm. Biochim Biophys Acta 1829: 169-173, 2013.
29. Dazard J-E, Gal H, Amariglio N, Rechavi G, Domany E, and Givol D. Genome-wide comparison of human keratinocytes and squamous cell carcinoma responses to UVB irradiation: implications for skin and epithelial cancer. Oncogene 22: 2993-3006, 2003.
30. Devany E, Zhang X, Park JY, Tian B, and Kleiman FE. Positive and negative feedback loops in the p53 and mRNA 3¢ processing pathways. Proc Natl Acad Sci USA 110: 3351-3356, 2013.
31. Devary Y, Rosette C, Didonato JA, and Karin M. NF-kappa-B Activation by Ultraviolet Light Not Dependent on a Nuclear Signal. Science 261: 1442-1445, 1993.
32. Doidge R, Mittal S, Aslam A, and Winkler GS. The antiproliferative activity of BTG/TOB proteins is mediated via 33. Doidge R, Mittal S, Aslam A, and Winkler GS. Deadenylation of cytoplasmic mRNA by the mammalian Ccr4-Not complex. Biochem Soc Trans 40: 896-901, 2012.
33. Dori-Bachash M, Shema E, and Tirosh I. Coupled evolution of transcription and mRNA degradation. PLoS Biol 9: e1001106, 2011.
34. Drogat J and Hermand D. Gene-specific requirement of RNA polymerase II CTD phosphorylation. Mol Microbiol 84: 995-1004, 2012.
35. Dujardin G, Lafaille C, Petrillo E, Buggiano V, Gomez Acuna LI, Fiszbein A, Godoy Herz MA, Nieto Moreno N, Munoz MJ, Allo M, Schor IE, and Kornblihtt AR. Transcriptional elongation and alternative splicing. Biochim Biophys Acta 1829: 134-140, 2013.
36. Egloff S, Dienstbier M, and Murphy S. Updating the RNA polymerase CTD code: adding gene-specific layers. Trends Genet 28: 333-341, 2012.
37. el-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, and Vogelstein B. WAF1, a potential mediator of p53 tumor suppression. Cell 75: 817-825, 1993.
38. Fan J, Yang X, Wang W, Wood WH, 3rd, Becker KG, and Gorospe M. Global analysis of stress-regulated mRNA turnover by using cDNA arrays. Proc Natl Acad Sci USA 99: 10611-10616, 2002.
39. Ford JM and Hanawalt PC. Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc Natl Acad Sci USA 92: 8876-8880, 1995.
40. Ford LP, Watson J, Keene JD, and Wilusz J. ELAV proteins stabilize deadenylated intermediates in a novel in vitro mRNA deadenylation/degradation system. Genes Dev 13: 188-201, 1999.
41. Fornace AJ, Jr., Alamo I, Jr., and Hollander MC. DNA damage-inducible transcripts in mammalian cells. Proc Natl Acad Sci USA 85: 8800-8804, 1988.
42. Francis MA, McKay BC, and Rainbow AJ. Recombinant adenoviruses as expression vectors and as probes for DNA repair in human cells. Gene Ther Mol Biol 5: 87-100, 2001.
43. Francis MA and Rainbow AJ. UV-enhanced expression of a reporter gene is induced at lower UV fluences in transcription-coupled repair deficient compared to normal human fibroblasts, and is absent in SV40-transformed counterparts. Photochem Photobiol 72: 554-561, 2000.
44. Francis MA and Rainbow AJ. Role for retinoblastoma protein family members in UV-enhanced expression from the human cytomegalovirus immediate early promoters. Photochem Photobiol 77: 621-627, 2003.
45. Friedel CC, Dolken L, Ruzsics Z, Koszinowski UH, and Zimmer R. Conserved principles of mammalian transcriptional regulation revealed by RNA half-life. Nucleic Acids Res 37: e115, 2009.
46. Fritz G and Kaina B. Transcriptional activation of the small GTPase gene rhoB by genotoxic stress is regulated via a CCAAT element. Nucleic Acids Res 29: 792-798, 2001.
47. Gentile M, Latonen L, and Laiho M. Cell cycle arrest and apoptosis provoked by UV radiation-induced DNA damage are transcriptionally highly divergent responses. Nucleic Acids Res 31: 4779-4790, 2003.
48. Giles KM, Daly JM, Beveridge DJ, Thomson AM, Voon DC, Furneaux HM, Jazayeri JA, and Leedman PJ. The 3¢-untranslated region of p21WAF1 mRNA is a composite cisacting sequence bound by RNA-binding proteins from breast cancer cells, including HuR and poly(C)-binding protein. J Biol Chem 278: 2937-2946, 2003.
49. Goler-Baron V, Selitrennik M, Barkai O, Haimovich G, Lotan R, and Choder M. Transcription in the nucleus and mRNA decay in the cytoplasm are coupled processes. Genes Dev 22: 2022-2027, 2008.
50. Gorospe M, Wang X, and Holbrook NJ. p53-dependent elevation of p21Waf1 expression by UV light is mediated through mRNA stabilization and involves a vanadatesensitive regulatory system. Mol Cell Biol 18: 1400-1407, 1998.
51. Gowrishankar G, Winzen R, Bollig F, Ghebremedhin B, Redich N, Ritter B, Resch K, Kracht M, and Holtmann H. Inhibition of mRNA deadenylation and degradation by ultraviolet light. Biol Chem 386: 1287-1293, 2005.
52. Gowrishankar G, Winzen R, Dittrich-Breiholz O, Redich N, Kracht M, and Holtmann H. Inhibition of mRNA deadenylation and degradation by different types of cell stress. Biol Chem 387: 323-327, 2006.
53. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, and Bartel DP. MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91-105, 2007.
54. Guo YL, Chang HC, Tsai JH, Huang JC, Li C, Young KC, Wu LW, Lai MD, Liu HS, and Huang W. Two UVCinduced stress response pathways in HeLa cells identified by cDNA microarray. Environ Mol Mutagen 40: 122-128, 2002.
55. Hafidh S, Capkova V, and Honys D. Safe keeping the message: mRNP complexes tweaking after transcription. Adv Exp Med Biol 722: 118-136, 2011.
56. Haimovich G, Choder M, Singer RH, and Trcek T. The fate of the messenger is pre-determined: A new model for regulation of gene expression. Biochim Biophys Acta 1829: 643-653, 2013.
57. Halees AS, Hitti E, Al-Saif M, Mahmoud L, Vlasova-St Louis IA, Beisang DJ, Bohjanen PR, and Khabar K. Global assessment of GU-rich regulatory content and function in the human transcriptome. RNA Biol 8: 681-691, 2011.
58. Hao S and Baltimore D. The stability of mRNA influences the temporal order of the induction of genes encoding inflammatory molecules. Nat Immunol 10: 281-288, 2009.
59. Harel-Sharvit L, Eldad N, Haimovich G, Barkai O, Duek L, and Choder M. RNA polymerase II subunits link transcription and mRNA decay to translation. Cell 143: 552-563, 2010.
60. Hattinger CM, Jochemsen AG, Tanke HJ, and Dirks RW. Induction of p21 mRNA synthesis after short-wavelength UV light visualized in individual cells by RNA FISH. J Histochem Cytochem 50: 81-89, 2002.
61. Hau HH, Walsh RJ, Ogilvie RL, Williams DA, Reilly CS, and Bohjanen PR. Tristetraprolin recruits functional mRNA decay complexes to ARE sequences. J Cell Biochem 100: 1477-1492, 2007.
62. Heidemann M, Hintermair C, Voss K, and Eick D. Dynamic phosphorylation patterns of RNA polymerase II CTD during transcription. Biochim Biophys Acta 1829: 55-62, 2013.
63. Hermeking H. The miR-34 family in cancer and apoptosis. Cell Death Differ 17: 193-199, 2010.
64. Hollstein M, Sidransky D, Vogelstein B, and Harris CC. p53 mutations in human cancers. Science 253: 49-53, 1991.
65. Jackman J, Alamo I, Jr., and Fornace AJ, Jr. Genotoxic stress confers preferential and coordinate messenger RNA stability on the five gadd genes. Cancer Res 54: 5656-5662, 1994.
66. Jackson RS, 2nd, Cho YJ, and Liang P. TIS11D is a candidate pro-apoptotic p53 target gene. Cell Cycle 5: 2889-2893, 2006.
67. Kaller M, Liffers ST, Oeljeklaus S, Kuhlmann K, Roh S, Hoffmann R, Warscheid B, and Hermeking H. Genomewide characterization of miR-34a induced changes in protein and mRNA expression by a combined pulsed SILAC and microarray analysis. Mol Cell Proteomics 10: M111.010462, 2011.
68. Kantor GJ and Hull DR. An effect of ultraviolet light on RNA and protein synthesis in nondividing human diploid fibroblasts. Biophys J 27: 359-370, 1979.
69. Kerr SC, Azzouz N, Fuchs SM, Collart MA, Strahl BD, Corbett AH, and Laribee RN. The Ccr4-Not complex interacts with the mRNA export machinery. PLoS One 6: e18302, 2011.
70. Kim HS, Li H, Cevher M, Parmelee A, Fonseca D, Kleiman FE, and Lee SB. DNA damage-induced BARD1 phosphorylation is critical for the inhibition of messenger RNA processing by BRCA1/BARD1 complex. Cancer Res 66: 4561-4565, 2006.
71. Kim NH, Kim HS, Li XY, Lee I, Choi HS, Kang SE, Cha SY, Ryu JK, Yoon D, Fearon ER, Rowe RG, Lee S, Maher CA, Weiss SJ, and Yook JI. A p53/miRNA-34 axis regulates Snail1-dependent cancer cell epithelial-mesenchymal transition. J Cell Biol 195: 417-433, 2011.
72. Kim T, Veronese A, Pichiorri F, Lee TJ, Jeon YJ, Volinia S, Pineau P, Marchio A, Palatini J, Suh SS, Alder H, Liu CG, Dejean A, and Croce CM. p53 regulates epithelialmesenchymal transition through microRNAs targeting ZEB1 and ZEB2. J Exp Med 208: 875-883, 2011.
73. Kleiman FE and Manley JL. Functional interaction of BRCA1-associated BARD1 with polyadenylation factor CstF-50. Science 285: 1576-1579, 1999.
74. Kleiman FE and Manley JL. The BARD1-CstF-50 interaction links mRNA 3¢ end formation to DNA damage and tumor suppression. Cell 104: 743-753, 2001.
75. Kleiman FE, Wu-Baer F, Fonseca D, Kaneko S, Baer R, and Manley JL. BRCA1/BARD1 inhibition of mRNA 3¢ processing involves targeted degradation of RNA polymerase II. Genes Dev 19: 1227-1237, 2005.
76. Korner I, WeberNordt R, Pfaff P, and Finke J. Analysis of a regulatory element in the 5¢-untranslated region of the bcl-2 gene. FEBS Lett 406: 31-32, 1997.
77. Krol J and Krzyzosiak WJ. Structure analysis of microRNA precursors. Methods Mol Biol 342: 19-32, 2006.
78. Krol J, Loedige I, and Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 11: 597-610, 2011.
79. Kruger J and Rehmsmeier M. RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res 34: W451-W454, 2006.
80. Kruk JA, Dutta A, Fu J, Gilmour DS, and Reese JC. The multifunctional Ccr4-Not complex directly promotes transcription elongation. Genes Dev 25: 581-593, 2011.
81. Lal A, Abdelmohsen K, Pullmann R, Kawai T, Galban S, Yang X, Brewer G, and Gorospe M. Posttranscriptional derepression of GADD45alpha by genotoxic stress. Mol Cell 22: 117-128, 2006.
82. Lal A, Mazan-Mamczarz K, Kawai T, Yang X, Martindale JL, and Gorospe M. Concurrent versus individual binding of HuR and AUF1 to common labile target mRNAs. EMBO J 23: 3092-3102, 2004.
83. Lee RC, Feinbaum RL, and Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75: 843-854, 1993.
84. Leung AK and Sharp PA. MicroRNA functions in stress responses. Mol Cell 40: 205-215, 2010.
85. Ljungman M. The transcription stress response. Cell Cycle 6: 2252-2257, 2007.
86. Ljungman M. The DNA damage response-repair or despair? Environ Mol Mutagen 51: 879-889, 2010.
87. Ljungman M and Lane DP. Transcription-guarding the genome by sensing DNA damage. Nat Rev Cancer 4: 727-737, 2004.
88. Ljungman M and Zhang F. Blockage of RNA polymerase as a possible trigger for u.v. light-induced apoptosis. Oncogene 13: 823-831, 1996.
89. Lu Y, Lian H, Sharma P, Schreiber-Agus N, Russell RG, Chin L, van der Horst GT, and Bregman DB. Disruption of the Cockayne syndrome B gene impairs spontaneous tumorigenesis in cancer-predisposed Ink4a/ARF knockout mice. Mol Cell Biol 21: 1810-1818, 2001.
90. Luo Z, Zheng J, Lu Y, and Bregman DB. Ultraviolet radiation alters the phosphorylation of RNA polymerase II large subunit and accelerates its proteasome-dependent degradation. Mutat Res 486: 259-274, 2001.
91. Ma WJ, Cheng S, Campbell C, Wright A, and Furneaux H. Cloning and characterization of HuR, a ubiquitously expressed Elav-like protein. J Biol Chem 271: 8144-8151, 1996.
92. Maltzman W and Czyzyk L. UV irradiation stimulates levels of p53 cellular tumor antigen in nontransformed mouse cells. Mol Cell Biol 4: 1689-1694, 1984.
93. Mandel CR, Bai Y, and Tong L. Protein factors in premRNA 3¢-end processing. Cell Mol Life Sci 65: 1099-1122, 2008.
94. Mandel CR, Kaneko S, Zhang H, Gebauer D, Vethantham V, Manley JL, and Tong L. Polyadenylation factor CPSF-73 is the pre-mRNA 3¢-end-processing endonuclease. Nature 444: 953-956, 2006.
95. Marengo MS and Garcia-Blanco MA. Shedding UV light on alternative splicing. Cell 137: 600-602, 2009.
96. Mata J, Marguerat S, and Bahler J. Post-transcriptional control of gene expression: a genome-wide perspective. Trends Biochem Sci 30: 506-514, 2005.
97. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, 3rd, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y, Shiloh Y, Gygi SP, and Elledge SJ. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 316: 1160-1166, 2007.
98. Mauxion F, Chen CY, Seraphin B, and Shyu AB. BTG/TOB factors impact deadenylases. Trends Biochem Sci 34: 640-647, 2009.
99. Mauxion F, Faux C, and Seraphin B. The BTG2 protein is a general activator of mRNA deadenylation. EMBO J 27: 1039-1048, 2008.
100. Mayne LV and Lehmann AR. Failure of RNA synthesis to recover after UV irradiation: an early defect in cells from individuals with Cockayne's syndrome and xeroderma pigmentosum. Cancer Res 42: 1473-1478, 1982.
101. Mazan-Mamczarz K, Galban S, Lopez de Silanes I, Martindale JL, Atasoy U, Keene JD, and Gorospe M. RNAbinding protein HuR enhances p53 translation in response to ultraviolet light irradiation. Proc Natl Acad Sci USA 100: 8354-8359, 2003.
102. McKay BC, Becerril C, and Ljungman M. P53 plays a protective role against UV-and cisplatin-induced apoptosis in transcription-coupled repair proficient fibroblasts. Oncogene 20: 6805-6808, 2001.
103. McKay BC and Cabrita MA. Arresting transcription and sentencing the cell: The consequences of blocked transcription. Mech Ageing Dev 134: 243-252, 2013.
104. McKay BC, Chen F, Clarke ST, Wiggin HE, Harley LM, and Ljungman M. UV light-induced degradation of RNA polymerase II is dependent on the Cockayne's syndrome A and B proteins but not p53 orMLH1. Mutat Res 485: 93-105, 2001.
105. McKay BC and Ljungman M. Role for p53 in the recovery of transcription and protection against apoptosis induced by ultraviolet light. Neoplasia 1: 276-284, 1999.
106. McKay BC, Ljungman M, and Rainbow AJ. Persistent DNA damage induced by ultraviolet light inhibits p21waf1 and bax expression: implications for DNA repair, UV sensitivity and the induction of apoptosis. Oncogene 17: 545-555, 1998.
107. McKay BC, Ljungman M, and Rainbow AJ. Potential roles for p53 in nucleotide excision repair. Carcinogenesis 20: 1389-1396, 1999.
108. McKay BC, Stubbert LJ, Fowler CC, Smith JM, Cardamore RA, and Spronck JC. Regulation of ultraviolet light-induced gene expression by gene size. Proc Natl Acad Sci USA 101: 6582-6586, 2004.
109. Melanson BD, Bose R, Hamill JD, Marcellus KA, Pan EF, and McKay BC. The role of mRNA decay in p53-induced gene expression. RNA 17: 2222-2234, 2011.
110. Melanson BD, Cabrita MA, Bose R, Hamill JD, Pan E, Brochu C, Marcellus KA, Zhao TT, Holcik M, and McKay BC. A novel cis-acting element from the 3¢UTR of DNA damage-binding protein 2 mRNA links transcriptional and post-transcriptional regulation of gene expression. Nucleic Acids Res 41: 5692-5703, 2013.
111. Mellon I, Spivak G, and Hanawalt PC. Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene. Cell 51: 241-249, 1987.
112. Miller JE and Reese JC. Ccr4-Not complex: the control freak of eukaryotic cells. Crit Rev Biochem Mol Biol 47: 315-333, 2012.
113. Mirkin N, Fonseca D, Mohammed S, Cevher MA, Manley JL, and Kleiman FE. The 3¢ processing factor CstF functions in the DNA repair response. Nucleic Acids Res 36: 1792-1804, 2008.
114. Montes M, Becerra S, Sanchez-Alvarez M, and Sune C. Functional coupling of transcription and splicing. Gene 501: 104-117, 2012.
115. Morf J, Rey G, Schneider K, Stratmann M, Fujita J, Naef F, and Schibler U. Cold-inducible RNA-binding protein modulates circadian gene expression posttranscriptionally. Science 338: 379-383, 2012.
116. Munoz MJ, de la Mata M, and Kornblihtt AR. The carboxy terminal domain of RNA polymerase II and alternative splicing. Trends Biochem Sci 35: 497-504, 2010.
117. Nazeer FI, Devany E, Mohammed S, Fonseca D, Akukwe B, Taveras C, and Kleiman FE. p53 inhibits mRNA 3¢ processing through its interaction with the CstF/BARD1 complex. Oncogene 30: 3073-3083, 2011.
118. Niida H and Nakanishi M. DNA damage checkpoints in mammals. Mutagenesis 21: 3-9, 2006.
119. Oeffinger M and Zenklusen D. To the pore and through the pore: a story of mRNA export kinetics. Biochim Biophys Acta 1819: 494-506, 2012.
120. Polo SE and Jackson SP. Dynamics of DNA damage response proteins at DNA breaks: a focus on protein modifications. Genes Dev 25: 409-433, 2011.
121. Pothof J, Verkaik NS, van IW, Wiemer EA, Ta VT, van der Horst GT, Jaspers NG, van Gent DC, Hoeijmakers JH, and Persengiev SP. MicroRNA-mediated gene silencing modulates the UV-induced DNA-damage response. EMBO J 28: 2090-2099, 2009.
122. Proudfoot NJ. Ending the message: poly(A) signals then and now. Genes Dev 25: 1770-1782, 2011.
123. Rabani M, Levin JZ, Fan L, Adiconis X, Raychowdhury R, Garber M, Gnirke A, Nusbaum C, Hacohen N, Friedman N, Amit I, and Regev A. Metabolic labeling of RNA uncovers principles of RNA production and degradation dynamics in mammalian cells. Nat Biotechnol 29: 436-442, 2011.
124. Radler-Pohl A, Sachsenmaier C, Gebel S, Auer HP, Bruder JT, Rapp U, Angel P, Rahmsdorf HJ, and Herrlich P. UVinduced activation of AP-1 involves obligatory extranuclear steps including Raf-1 kinase. EMBO J 12: 1005-1012, 1993.
125. Raghavan A and Bohjanen PR. Microarray-based analyses of mRNA decay in the regulation of mammalian gene expression. Brief Funct Genomic Proteomic 3: 112-124, 2004.
126. Rashi-Elkeles S, Elkon R, Shavit S, Lerenthal Y, Linhart C, Kupershtein A, Amariglio N, Rechavi G, Shamir R, and Shiloh Y. Transcriptional modulation induced by ionizing radiation: p53 remains a central player. Mol Oncol 5: 336-348, 2011.
127. Ratner JN, Balasubramanian B, Corden J, Warren SL, and Bregman DB. Ultraviolet radiation-induced ubiquitination and proteasomal degradation of the large subunit of RNA polymerase II-Implications for transcription-coupled DNA repair. J Biol Chem 273: 5184-5189, 1998.
128. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z, and Oren M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 26: 731-743, 2007.
129. Reinhardt HC, Cannell IG, Morandell S, and Yaffe MB. Is post-transcriptional stabilization, splicing and translation of selective mRNAs a key to the DNA damage response? Cell Cycle 10: 23-27, 2011.
130. Reinhardt HC, Hasskamp P, Schmedding I, Morandell S, van Vugt MA, Wang X, Linding R, Ong SE, Weaver D, Carr SA, and Yaffe MB. DNA damage activates a spatially distinct late cytoplasmic cell-cycle checkpoint network controlled by MK2-mediated RNA stabilization. Mol Cell 40: 34-49, 2010.
131. Roberts GC, Gooding C, Mak HY, Proudfoot NJ, and Smith CW. Co-transcriptional commitment to alternative splice site selection. Nucleic Acids Res 26: 5568-5572, 1998.
132. Rockx DA, Mason R, van Hoffen A, Barton MC, Citterio E, Bregman DB, van Zeeland AA, Vrieling H, and Mullenders LH. UV-induced inhibition of transcription involves repression of transcription initiation and phosphorylation of RNA polymerase II. Proc Natl Acad Sci USA 97: 10503-10508, 2000.
133. Rouault JP, Falette N, Guehenneux F, Guillot C, Rimokh R, Wang Q, Berthet C, Moyret-Lalle C, Savatier P, Pain B, Shaw P, Berger R, Samarut J, Magaud JP, Ozturk M, Samarut C, and Puisieux A. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet 14: 482-486, 1996.
134. Sachs A. The role of poly(A) in the translation and stability of mRNA. Curr Opin Cell Biol 2: 1092-1098, 1990.
135. Sauerbier W and Hercules K. Gene and transcription unit mapping by radiation effects. Annu Rev Genet 12: 329-363, 1978.
136. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, and Rajewsky N. Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63, 2008.
137. Selby CP, Drapkin R, Reinberg D, and Sancar A. RNA polymerase II stalled at a thymine dimer: Footprint and effect on excision repair. Nucleic Acids Res 25: 787-793, 1997.
138. Sharova LV, Sharov AA, Nedorezov T, Piao Y, Shaik N, and Ko MS. Database for mRNA half-life of 19 977 genes obtained by DNA microarray analysis of pluripotent and differentiating mouse embryonic stem cells. DNA Res 16: 45-58, 2009.
139. Shim J and Karin M. The control of mRNA stability in response to extracellular stimuli. Mol Cells 14: 323-331, 2002.
140. Shin C, Nam JW, Farh KK, Chiang HR, Shkumatava A, and Bartel DP. Expanding the microRNA targeting code: functional sites with centered pairing. Mol Cell 38: 789-802, 2010.
141. Shyu AB, Wilkinson MF, and van Hoof A. Messenger RNA regulation: to translate or to degrade. EMBO J 27: 471-481, 2008.
142. Singer S, Zhao R, Barsotti AM, Ouwehand A, Fazollahi M, Coutavas E, Breuhahn K, Neumann O, Longerich T, Pusterla T, Powers MA, Giles KM, Leedman PJ, Hess J, Grunwald D, Bussemaker HJ, Singer RH, Schirmacher P, and Prives C. Nuclear pore component Nup98 is a potential tumor suppressor and regulates posttranscriptional expression of select p53 target genes. Mol Cell 48: 799-810, 2012.
143. Stoecklin G, Ming XF, Looser R, and Moroni C. Somatic mRNA turnover mutants implicate tristetraprolin in the interleukin-3 mRNA degradation pathway. Mol Cell Biol 20: 3753-3763, 2000.
144. Suzuki HI, Yamagata K, Sugimoto K, Iwamoto T, Kato S, and Miyazono K. Modulation of microRNA processing by p53. Nature 460: 529-533, 2009.
145. Svejstrup JQ. The RNA polymerase II transcription cycle: cycling through chromatin. Biochim Biophys Acta 1677: 64-73, 2004.
146. Tan T and Chu G. p53 Binds and activates the xeroderma pigmentosum DDB2 gene in humans but not mice. Mol Cell Biol 22: 3247-3254, 2002.
147. Tarasov V, Jung P, Verdoodt B, Lodygin D, Epanchintsev A, Menssen A, Meister G, and Hermeking H. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 6: 1586-1593, 2007.
148. Tornaletti S, Donahue BA, Reines D, and Hanawalt PC. Nucleotide sequence context effect of a cyclobutane pyrimidine dimer upon RNA polymerase II transcription. J Biol Chem 272: 31719-31724, 1997.
149. Tornaletti S and Hanawalt PC. Effect of DNA lesions on transcription elongation. Biochimie 81: 139-146, 1999.
150. Trcek T, Sato H, Singer RH, and Maquat LE. Temporal and spatial characterization of nonsense-mediated mRNA decay. Genes Dev 27: 541-551, 2013.
151. van Hoffen A, Venema J, Meschini R, Vanzeeland AA, and Mullenders LHF. Transcription-coupled repair removes both cyclobutane pyrimidine dimers and 6-4 photoproducts with equal efficiency and in a sequential way from transcribed DNA in xeroderma pigmentosum group C fibroblasts. EMBO J 14: 360-367, 1995.
152. van Steeg H and Kraemer KH. Xeroderma pigmentosum and the role of UV-induced DNA damage in skin cancer. Mol Med Today 5: 86-94, 1999.
153. Velez-Cruz R, Zadorin AS, Coin F, and Egly JM. Sirt1 suppresses RNA synthesis after UV irradiation in combined xeroderma pigmentosum group D/Cockayne syndrome (XP-D/CS) cells. Proc Natl Acad Sci USA 110: E212-E220, 2012.
154. Venema J, Mullenders LHF, Natarajan AT, van Zeeland AA, and Mayne LV. The genetic defect in Cockayne syndrome is associated with a defect in repair of UV-induced DNA damage in transcriptionally active DNA. Proc Natl Acad Sci USA 87: 4707-4711, 1990.
155. Venema J, van Hoffen A, Natarajan AT, van Zeeland AA, and Mullenders LHF. The residual repair capacity of xeroderma pigmentosum complementation group C fibroblasts is highly specific for transcriptionally active DNA. Nucleic Acids Res 18: 443-448, 1990.
156. Venema J, Vanhoffen A, Karcagi V, Natarajan AT, Vanzeeland AA, and Mullenders LHF. Xeroderma-pigmentosum complementation group-C cells remove pyrimidine dimers selectively from the transcribed strand of active genes. Mol Cell Biol 11: 4128-4134, 1991.
157. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, Gocayne JD, Amanatides P, Ballew RM, Huson DH, Wortman JR, Zhang Q, Kodira CD, Zheng XH, Chen L, Skupski M, Subramanian G, Thomas PD, Zhang J, Gabor Miklos GL, Nelson C, Broder S, Clark AG, Nadeau J, McKusick VA, Zinder N, Levine AJ, Roberts RJ, Simon M, Slayman C, Hunkapiller M, Bolanos R, Delcher A, Dew I, Fasulo D, Flanigan M, Florea L, Halpern A, Hannenhalli S, Kravitz S, Levy S, Mobarry C, Reinert K, Remington K, Abu-Threideh J, Beasley E, Biddick K, Bonazzi V, Brandon R, Cargill M, Chandramouliswaran I, Charlab R, Chaturvedi K, Deng Z, Di Francesco V, Dunn P, Eilbeck K, Evangelista C, Gabrielian AE, Gan W, Ge W, Gong F, Gu Z, Guan P, Heiman TJ, Higgins ME, Ji RR, Ke Z, Ketchum KA, Lai Z, Lei Y, Li Z, Li J, Liang Y, Lin X, Lu F, Merkulov GV, Milshina N, Moore HM, Naik AK, Narayan VA, Neelam B, Nusskern D, Rusch DB, Salzberg S, Shao W, Shue B, Sun J, Wang Z, Wang A, Wang X, Wang J, Wei M, Wides R, Xiao C, Yan C, Yao A, Ye J, Zhan M, Zhang W, Zhang H, Zhao Q, Zheng L, Zhong F, Zhong W, Zhu S, Zhao S, Gilbert D, Baumhueter S, Spier G, Carter C, Cravchik A, Woodage T, Ali F, An H, Awe A, Baldwin D, Baden H, Barnstead M, Barrow I, Beeson K, Busam D, Carver A, Center A, Cheng ML, Curry L, Danaher S, Davenport L, Desilets R, Dietz S, Dodson K, Doup L, Ferriera S, Garg N, Gluecksmann A, Hart B, Haynes J, Haynes C, Heiner C, Hladun S, Hostin D, Houck J, Howland T, Ibegwam C, Johnson J, Kalush F, Kline L, Koduru S, Love A, Mann F, May D, McCawley S, McIntosh T, McMullen I, Moy M, Moy L, Murphy B, Nelson K, Pfannkoch C, Pratts E, Puri V, Qureshi H, Reardon M, Rodriguez R, Rogers YH, Romblad D, Ruhfel B, Scott R, Sitter C, Smallwood M, Stewart E, Strong R, Suh E, Thomas R, Tint NN, Tse S, Vech C, Wang G, Wetter J, Williams S, Williams M, Windsor S, Winn-Deen E, Wolfe K, Zaveri J, Zaveri K, Abril JF, Guigo R, Campbell MJ, Sjolander KV, Karlak B, Kejariwal A, Mi H, Lazareva B, Hatton T, Narechania A, Diemer K, Muruganujan A, Guo N, Sato S, Bafna V, Istrail S, Lippert R, Schwartz R, Walenz B, Yooseph S, Allen D, Basu A, Baxendale J, Blick L, Caminha M, Carnes-Stine J, Caulk P, Chiang YH, Coyne M, Dahlke C, Mays A, Dombroski M, Donnelly M, Ely D, Esparham S, Fosler C, Gire H, Glanowski S, Glasser K, Glodek A, Gorokhov M, Graham K, Gropman B, Harris M, Heil J, Henderson S, Hoover J, Jennings D, Jordan C, Jordan J, Kasha J, Kagan L, Kraft C, Levitsky A, Lewis M, Liu X, Lopez J, Ma D, Majoros W, McDaniel J, Murphy S, Newman M, Nguyen T, Nguyen N, Nodell M, Pan S, Peck J, Peterson M, Rowe W, Sanders R, Scott J, Simpson M, Smith T, Sprague A, Stockwell T, Turner R, Venter E, Wang M, Wen M, Wu D, Wu M, Xia A, Zandieh A, and Zhu X. The sequence of the human genome. Science 291: 1304-1351, 2001.
158. Vichi P, Coin F, Renaud JP, Vermeulen W, Hoeijmakers JHJ, Moras D, and Egly JM. Cisplatin-and UV-damaged DNA lure the basal transcription factor TFIID/TBP. EMBO J 16: 7444-7456, 1997.
159. Wang W, Furneaux H, Cheng H, Caldwell MC, Hutter D, Liu Y, Holbrook N, and Gorospe M. HuR regulates p21 mRNA stabilization by UV light. Mol Cell Biol 20: 760-769, 2000.
160. Westmark CJ, Bartleson VB, and Malter JS. RhoB mRNA is stabilized by HuR after UV light. Oncogene 24: 502-511, 2005.
161. Wightman B, Ha I, and Ruvkun G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell 75: 855-862, 1993.
162. Winkler GS. The mammalian anti-proliferative BTG/Tob protein family. J Cell Physiol 222: 66-72, 2010.
163. Yang C and Carrier F. The UV-inducible RNA-binding protein A18 (A18 hnRNP) plays a protective role in the genotoxic stress response. J Biol Chem 276: 47277-47284, 2001.
164. Yang E, van Nimwegen E, Zavolan M, Rajewsky N, Schroeder M, Magnasco M, and Darnell JE, Jr. Decay rates of human mRNAs: correlation with functional characteristics and sequence attributes. Genome Res 13: 1863-1872, 2003.
165. Yang R, Zhan M, Nalabothula NR, Yang Q, Indig FE, and Carrier F. Functional significance for a heterogenous ribonucleoprotein A18 signature RNA motif in the 3¢-untranslated region of ataxia telangiectasia mutated and Rad3-related (ATR) transcript. J Biol Chem 285: 8887-8893, 2010.
166. Zhang J, Sun Q, Zhang Z, Ge S, Han ZG, and Chen WT. Loss of microRNA-143/145 disturbs cellular growth and apoptosis of human epithelial cancers by impairing the MDM2-p53 feedback loop. Oncogene 32: 61-69, 2013.
167. Zhao R, Gish K, Murphy M, Yin Y, Notterman D, Hoffman WH, Tom E, Mack DH, and Levine AJ. Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev 14: 981-993, 2000.
168. Zhou J, Lim CU, Li JJ, Cai L, and Zhang Y. The role of NBS1 in the modulation of PIKK family proteins ATM and ATR in the cellular response to DNA damage. Cancer Lett 243: 9-15, 2006.